Patients undergoing surgery after contracting coronavirus are at greatly increased risk of postoperative death, a new global study published in The Lancet reveals.
A new study led by the Universities of Birmingham and Oxford has found the mortality rate in cancer patients who are assessed or treated in hospital with COVID-19 is not significantly affected by anti-cancer treatments.
A team will coordinate the UK arm of a critical European clinical trial which could lead to the development of more effective and kinder treatments for children diagnosed with a rare and aggressive childhood cancer.
Over 28 million elective surgeries across the globe could be cancelled as a result of the COVID-19 pandemic – leading to patients facing a lengthy wait for their health issues to be resolved, a new study reveals.
Three professors from the University of Birmingham have been named among the UK's most prominent biomedical and health scientists by the Academy of Medical Sciences in its prestigious list of Fellows.
A trial which will rapidly test new therapies for patients hospitalised due to COVID-19 is opening in Birmingham this week.
Sarcoma UK: Professor Andrew Beggs hopes to use the DNA of cancer cells to answer a very pressing question – why don't sarcomas respond well to immunotherapy?
Labs at the University of Birmingham have been re-purposed to support the testing of frontline NHS staff in the city from this week.
A team of oncologists have joined forces to launch the first cancer coronavirus registry in the world to track how cancer patients who have tested positive for COVID-19 will be impacted.
International surgical guidelines launched today (25 March) will help to save thousands of lives in Low- and Middle-income Countries (LMIC) countries by standardising and improving practice in surgery.